Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 509

1.

Paget's disease of the nipple in a Her2-positive breast cancer xenograft model.

Drews-Elger K, Sandoval-Leon AC, Ergonul AB, Jegg AM, Gomez-Fernandez C, Miller PC, El-Ashry D, Lippman ME.

Breast Cancer Res Treat. 2019 Nov 13. doi: 10.1007/s10549-019-05490-8. [Epub ahead of print]

PMID:
31720992
2.

BCRT: a brief valedictory.

Lippman M.

Breast Cancer Res Treat. 2019 Dec;178(3):483. doi: 10.1007/s10549-019-05475-7. No abstract available.

PMID:
31620933
3.

A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer.

Speransky S, Serafini P, Caroli J, Bicciato S, Lippman ME, Bishopric NH.

Breast Cancer Res Treat. 2019 Jul;176(2):271-289. doi: 10.1007/s10549-019-05174-3. Epub 2019 Apr 20.

4.

RAC1b Overexpression Confers Resistance to Chemotherapy Treatment in Colorectal Cancer.

Goka ET, Chaturvedi P, Lopez DTM, Garza A, Lippman ME.

Mol Cancer Ther. 2019 May;18(5):957-968. doi: 10.1158/1535-7163.MCT-18-0955. Epub 2019 Mar 29.

PMID:
30926638
5.

Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer.

Lippman M.

Lancet Oncol. 2019 Mar;20(3):312-313. doi: 10.1016/S1470-2045(18)30913-6. Epub 2019 Feb 19. No abstract available.

PMID:
30795949
6.

The effects of a randomized trial of brief forms of stress management on RAGE-associated S100A8/A9 in patients with breast cancer undergoing primary treatment.

Taub CJ, Lippman ME, Hudson BI, Blomberg BB, Diaz A, Fisher HM, Nahin ER, Lechner SC, Kwak T, Hwang GH, Antoni MH.

Cancer. 2019 May 15;125(10):1717-1725. doi: 10.1002/cncr.31965. Epub 2019 Jan 11.

PMID:
30633331
7.

Reduction of Cisplatin-Induced Ototoxicity without Compromising Its Antitumor Activity.

Surnar B, Kolishetti N, Basu U, Ahmad A, Goka E, Marples B, Kolb D, Lippman ME, Dhar S.

Biochemistry. 2018 Nov 20;57(46):6500-6513. doi: 10.1021/acs.biochem.8b00712. Epub 2018 Nov 7.

PMID:
30281285
8.

Endocrine Adjuvant Therapy for Localized Breast Cancer.

Lippman ME.

N Engl J Med. 2018 Jul 12;379(2):193-194. doi: 10.1056/NEJMe1806130. Epub 2018 Jun 4. No abstract available.

PMID:
29863436
9.

The naloxone option.

Prabhu A, Abaid B, Khaleel MS, Naik S, Lippman M, Lippman S.

J Fam Pract. 2018 May;67(5):288;290;292.

PMID:
29726853
10.

Targeting RAGE Signaling in Inflammatory Disease.

Hudson BI, Lippman ME.

Annu Rev Med. 2018 Jan 29;69:349-364. doi: 10.1146/annurev-med-041316-085215. Epub 2017 Nov 6. Review.

PMID:
29106804
11.

Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study.

Dirix LY, Takacs I, Jerusalem G, Nikolinakos P, Arkenau HT, Forero-Torres A, Boccia R, Lippman ME, Somer R, Smakal M, Emens LA, Hrinczenko B, Edenfield W, Gurtler J, von Heydebreck A, Grote HJ, Chin K, Hamilton EP.

Breast Cancer Res Treat. 2018 Feb;167(3):671-686. doi: 10.1007/s10549-017-4537-5. Epub 2017 Oct 23.

12.

Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome.

Miller P, Kidwell KM, Thomas D, Sabel M, Rae JM, Hayes DF, Hudson BI, El-Ashry D, Lippman ME.

Breast Cancer Res Treat. 2017 Nov;166(1):85-94. doi: 10.1007/s10549-017-4366-6. Epub 2017 Jul 17.

PMID:
28717852
13.

Stress management, leukocyte transcriptional changes and breast cancer recurrence in a randomized trial: An exploratory analysis.

Antoni MH, Bouchard LC, Jacobs JM, Lechner SC, Jutagir DR, Gudenkauf LM, Carver CS, Lutgendorf S, Cole SW, Lippman M, Blomberg BB.

Psychoneuroendocrinology. 2016 Dec;74:269-277. doi: 10.1016/j.psyneuen.2016.09.012. Epub 2016 Sep 24.

14.

Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis.

Kwak T, Drews-Elger K, Ergonul A, Miller PC, Braley A, Hwang GH, Zhao D, Besser A, Yamamoto Y, Yamamoto H, El-Ashry D, Slingerland JM, Lippman ME, Hudson BI.

Oncogene. 2017 Mar;36(11):1559-1572. doi: 10.1038/onc.2016.324. Epub 2016 Sep 26.

PMID:
27669433
15.

Identification of Cancer-Associated Fibroblasts in Circulating Blood from Patients with Metastatic Breast Cancer.

Ao Z, Shah SH, Machlin LM, Parajuli R, Miller PC, Rawal S, Williams AJ, Cote RJ, Lippman ME, Datar RH, El-Ashry D.

Cancer Res. 2015 Nov 15;75(22):4681-7. doi: 10.1158/0008-5472.CAN-15-1633. Epub 2015 Oct 15.

16.

Loss of the E3 ubiquitin ligase HACE1 results in enhanced Rac1 signaling contributing to breast cancer progression.

Goka ET, Lippman ME.

Oncogene. 2015 Oct 16;34(42):5395-405. doi: 10.1038/onc.2014.468. Epub 2015 Feb 9.

17.

Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research.

Moossdorff M, van Roozendaal LM, Strobbe LJ, Aebi S, Cameron DA, Dixon JM, Giuliano AE, Haffty BG, Hickey BE, Hudis CA, Klimberg VS, Koczwara B, Kühn T, Lippman ME, Lucci A, Piccart M, Smith BD, Tjan-Heijnen VC, van de Velde CJ, Van Zee KJ, Vermorken JB, Viale G, Voogd AC, Wapnir IL, White JR, Smidt ML.

J Natl Cancer Inst. 2014 Nov 7;106(12). pii: dju288. doi: 10.1093/jnci/dju288. Print 2014 Dec.

18.

Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome.

Drews-Elger K, Iorns E, Dias A, Miller P, Ward TM, Dean S, Clarke J, Campion-Flora A, Rodrigues DN, Reis-Filho JS, Rae JM, Thomas D, Berry D, El-Ashry D, Lippman ME.

Breast Cancer Res Treat. 2014 Nov;148(1):41-59. doi: 10.1007/s10549-014-3122-4. Epub 2014 Oct 1.

PMID:
25270120
19.

A review of clinical aspects of breast cancer.

Libson S, Lippman M.

Int Rev Psychiatry. 2014 Feb;26(1):4-15. doi: 10.3109/09540261.2013.852971. Review.

PMID:
24716497
20.

Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures.

Drews-Elger K, Brinkman JA, Miller P, Shah SH, Harrell JC, da Silva TG, Ao Z, Schlater A, Azzam DJ, Diehl K, Thomas D, Slingerland JM, Perou CM, Lippman ME, El-Ashry D.

Breast Cancer Res Treat. 2014 Apr;144(3):503-17. doi: 10.1007/s10549-014-2887-9. Epub 2014 Feb 25.

PMID:
24567196
21.

CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-up.

Dan T, Hewitt SM, Ohri N, Ly D, Soule BP, Smith SL, Matsuda K, Council C, Shankavaram U, Lippman ME, Mitchell JB, Camphausen K, Simone NL.

Breast Cancer Res Treat. 2014 Jan;143(1):11-8. doi: 10.1007/s10549-013-2758-9. Epub 2013 Nov 26.

PMID:
24276281
22.

Paget's disease of the nipple.

Sandoval-Leon AC, Drews-Elger K, Gomez-Fernandez CR, Yepes MM, Lippman ME.

Breast Cancer Res Treat. 2013 Aug;141(1):1-12. doi: 10.1007/s10549-013-2661-4. Epub 2013 Aug 9. Review.

PMID:
23929251
23.

Assessment of implicit sexual associations in non-incarcerated pedophiles.

van Leeuwen ML, van Baaren RB, Chakhssi F, Loonen MG, Lippman M, Dijksterhuis A.

Arch Sex Behav. 2013 Nov;42(8):1501-7. doi: 10.1007/s10508-013-0094-0. Epub 2013 Apr 24.

PMID:
23613137
24.

Circulating tumor DNA--ready for prime time?

Lippman M, Osborne CK.

N Engl J Med. 2013 Mar 28;368(13):1249-50. doi: 10.1056/NEJMe1301249. Epub 2013 Mar 13. No abstract available.

PMID:
23484798
25.

Editorial. Preface.

Lippman M.

J Mammary Gland Biol Neoplasia. 2012 Dec;17(3-4):189-90. doi: 10.1007/s10911-012-9270-4. No abstract available.

PMID:
23247594
26.

A new mouse model for the study of human breast cancer metastasis.

Iorns E, Drews-Elger K, Ward TM, Dean S, Clarke J, Berry D, El Ashry D, Lippman M.

PLoS One. 2012;7(10):e47995. doi: 10.1371/journal.pone.0047995. Epub 2012 Oct 31.

27.

Truncated p110 ERBB2 induces mammary epithelial cell migration, invasion and orthotopic xenograft formation, and is associated with loss of phosphorylated STAT5.

Ward TM, Iorns E, Liu X, Hoe N, Kim P, Singh S, Dean S, Jegg AM, Gallas M, Rodriguez C, Lippman M, Landgraf R, Pegram MD.

Oncogene. 2013 May 9;32(19):2463-74. doi: 10.1038/onc.2012.256. Epub 2012 Jul 2.

28.

Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressor.

Iorns E, Ward TM, Dean S, Jegg A, Thomas D, Murugaesu N, Sims D, Mitsopoulos C, Fenwick K, Kozarewa I, Naceur-Lombarelli C, Zvelebil M, Isacke CM, Lord CJ, Ashworth A, Hnatyszyn HJ, Pegram M, Lippman M.

Breast Cancer Res Treat. 2012 Aug;135(1):79-91. doi: 10.1007/s10549-012-2068-7. Epub 2012 Apr 26.

PMID:
22535017
29.

Mechanisms of estrogen-independent breast cancer growth driven by low estrogen concentrations are unique versus complete estrogen deprivation.

Sikora MJ, Strumba V, Lippman ME, Johnson MD, Rae JM.

Breast Cancer Res Treat. 2012 Aug;134(3):1027-39. doi: 10.1007/s10549-012-2032-6. Epub 2012 Mar 29.

30.

Chaos theory and a career in medicine.

Lippman M.

Endocr Relat Cancer. 2012 Jan 9;19(1):P1-3. doi: 10.1530/ERC-11-0341. Print 2012 Feb. No abstract available.

PMID:
22232543
31.

Rescue of tropomyosin deficiency in Drosophila and human cancer cells by synaptopodin reveals a role of tropomyosin α in RhoA stabilization.

Wong JS, Iorns E, Rheault MN, Ward TM, Rashmi P, Weber U, Lippman ME, Faul C, Mlodzik M, Mundel P.

EMBO J. 2012 Feb 15;31(4):1028-40. doi: 10.1038/emboj.2011.464. Epub 2011 Dec 13.

32.

Twenty-five year results of the national cancer institute randomized breast conservation trial.

Simone NL, Dan T, Shih J, Smith SL, Sciuto L, Lita E, Lippman ME, Glatstein E, Swain SM, Danforth DN, Camphausen K.

Breast Cancer Res Treat. 2012 Feb;132(1):197-203. doi: 10.1007/s10549-011-1867-6. Epub 2011 Nov 24.

PMID:
22113254
33.

Simultaneous analysis of tumor and stromal gene expression profiles from xenograft models.

Iorns E, Clarke J, Ward T, Dean S, Lippman M.

Breast Cancer Res Treat. 2012 Jan;131(1):321-4. doi: 10.1007/s10549-011-1784-8. Epub 2011 Sep 24.

PMID:
21947683
34.

The role of SATB1 in breast cancer pathogenesis.

Iorns E, Hnatyszyn HJ, Seo P, Clarke J, Ward T, Lippman M.

J Natl Cancer Inst. 2010 Aug 18;102(16):1284-96. doi: 10.1093/jnci/djq243. Epub 2010 Jul 1.

PMID:
20595686
35.

AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis.

Zerp SF, Stoter R, Kuipers G, Yang D, Lippman ME, van Blitterswijk WJ, Bartelink H, Rooswinkel R, Lafleur V, Verheij M.

Radiat Oncol. 2009 Oct 23;4:47. doi: 10.1186/1748-717X-4-47.

36.

Correlation of GREB1 mRNA with protein expression in breast cancer: validation of a novel GREB1 monoclonal antibody.

Hnatyszyn HJ, Liu M, Hilger A, Herbert L, Gomez-Fernandez CR, Jorda M, Thomas D, Rae JM, El-Ashry D, Lippman ME.

Breast Cancer Res Treat. 2010 Jul;122(2):371-80. doi: 10.1007/s10549-009-0584-x. Epub 2009 Oct 20.

PMID:
19842031
37.

Editorial: Cost-effective analyses in Breast Cancer Research and Treatment [corrected].

Lippman ME, Ethier S, Hayes DF.

Breast Cancer Res Treat. 2009 May;115(2):221-2. doi: 10.1007/s10549-009-0414-1. No abstract available. Erratum in: Breast Cancer Res Treat. doi: 10.1007/s10549-010-0743-0.

PMID:
19449205
38.

Anti-vascular therapy: a new approach to cancer treatment.

Hayes AJ, Li LY, Lippman ME.

West J Med. 2000 Jan;172(1):39-42. No abstract available.

39.
40.

The androgen metabolite 5alpha-androstane-3beta,17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance.

Sikora MJ, Cordero KE, Larios JM, Johnson MD, Lippman ME, Rae JM.

Breast Cancer Res Treat. 2009 May;115(2):289-96. doi: 10.1007/s10549-008-0080-8. Epub 2008 Jun 4.

41.

A transcriptional fingerprint of estrogen in human breast cancer predicts patient survival.

Yu J, Yu J, Cordero KE, Johnson MD, Ghosh D, Rae JM, Chinnaiyan AM, Lippman ME.

Neoplasia. 2008 Jan;10(1):79-88.

42.

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, Speed T, Spellman PT, DeVries S, Lapuk A, Wang NJ, Kuo WL, Stilwell JL, Pinkel D, Albertson DG, Waldman FM, McCormick F, Dickson RB, Johnson MD, Lippman M, Ethier S, Gazdar A, Gray JW.

Cancer Cell. 2006 Dec;10(6):515-27.

43.

A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up.

Walshe JM, Berman AW, Vatas U, Steinberg SM, Anderson WF, Lippman ME, Swain SM.

Breast Cancer Res Treat. 2007 Jun;103(2):177-83. Epub 2006 Oct 13.

PMID:
17039267
44.

Effect of raloxifene on the incidence of invasive breast cancer in postmenopausal women with osteoporosis categorized by breast cancer risk.

Lippman ME, Cummings SR, Disch DP, Mershon JL, Dowsett SA, Cauley JA, Martino S.

Clin Cancer Res. 2006 Sep 1;12(17):5242-7.

45.

Knowledge mapping as a technique to support knowledge translation.

Ebener S, Khan A, Shademani R, Compernolle L, Beltran M, Lansang M, Lippman M.

Bull World Health Organ. 2006 Aug;84(8):636-42.

46.

New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK.

Hayes DF, Ethier S, Lippman ME.

Breast Cancer Res Treat. 2006 Nov;100(2):237-8. Epub 2006 Jun 14. No abstract available.

PMID:
16773436
47.

Wanted: cancer boss.

McDonald D, Vogelstein B, King MC, Hong WK, Augustin H, Hanahan D, Lippman M.

Nature. 2006 Apr 20;440(7087):978-9. No abstract available.

48.

Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors.

Creighton CJ, Cordero KE, Larios JM, Miller RS, Johnson MD, Chinnaiyan AM, Lippman ME, Rae JM.

Genome Biol. 2006;7(4):R28. Epub 2006 Apr 7.

49.

GREB1 is a novel androgen-regulated gene required for prostate cancer growth.

Rae JM, Johnson MD, Cordero KE, Scheys JO, Larios JM, Gottardis MM, Pienta KJ, Lippman ME.

Prostate. 2006 Jun 1;66(8):886-94.

PMID:
16496412
50.

A multicenter randomized clinical trial evaluating interleukin-2 activated hematopoietic stem cell transplantation and post-transplant IL-2 for high risk breast cancer patients.

Isaacs C, Slack R, Gehan E, Ballen K, Boccia R, Areman E, Kramer R, Hayes DF, Herscowitz H, Lippman M.

Breast Cancer Res Treat. 2005 Sep;93(2):125-34.

Supplemental Content

Loading ...
Support Center